Free Trial

Capital Research Global Investors Purchases 7,293,009 Shares of UnitedHealth Group Incorporated $UNH

UnitedHealth Group logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Capital Research Global Investors boosted its UnitedHealth stake by 126.9%, buying 7,293,009 shares to hold 13,042,049 shares worth about $4.50 billion, making UNH its 24th-largest position.
  • UnitedHealth slightly beat expectations with Q EPS of $2.11 versus $2.09 and reported revenue of $113.73 billion (up 12.3% year-over-year); analysts project roughly 29.54 EPS for the current year.
  • The company declared a quarterly dividend of $2.21 (annualized $8.84, yield ~3.1%, ex-dividend March 9, payable March 17) and holds a MarketBeat consensus rating of Moderate Buy with a $372.13 target price.
  • Interested in UnitedHealth Group? Here are five stocks we like better.

Capital Research Global Investors grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 126.9% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 13,042,049 shares of the healthcare conglomerate's stock after buying an additional 7,293,009 shares during the quarter. UnitedHealth Group accounts for 0.8% of Capital Research Global Investors' portfolio, making the stock its 24th largest position. Capital Research Global Investors owned about 1.44% of UnitedHealth Group worth $4,503,419,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in UNH. Sagard Holdings Management Inc. bought a new position in shares of UnitedHealth Group during the second quarter valued at $29,000. Foster Dykema Cabot & Partners LLC grew its position in shares of UnitedHealth Group by 69.4% during the 3rd quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 34 shares during the period. Islay Capital Management LLC purchased a new position in UnitedHealth Group during the second quarter valued at $31,000. Hurley Capital LLC lifted its position in shares of UnitedHealth Group by 81.6% during the 3rd quarter. Hurley Capital LLC now owns 89 shares of the healthcare conglomerate's stock valued at $31,000 after buying an additional 40 shares in the last quarter. Finally, Cloud Capital Management LLC bought a new position in shares of UnitedHealth Group in the third quarter worth approximately $32,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Down 0.5%

Shares of NYSE UNH opened at $284.97 on Tuesday. The company has a debt-to-equity ratio of 0.72, a current ratio of 0.79 and a quick ratio of 0.79. The firm has a 50-day simple moving average of $307.41 and a two-hundred day simple moving average of $325.89. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $606.36. The company has a market cap of $258.67 billion, a P/E ratio of 21.61, a PEG ratio of 1.32 and a beta of 0.41.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The firm had revenue of $113.73 billion during the quarter, compared to analyst estimates of $113.38 billion. During the same period last year, the company earned $6.81 EPS. UnitedHealth Group's quarterly revenue was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th will be given a $2.21 dividend. This represents a $8.84 annualized dividend and a yield of 3.1%. The ex-dividend date of this dividend is Monday, March 9th. UnitedHealth Group's payout ratio is 67.02%.

Analyst Ratings Changes

Several analysts recently issued reports on the company. Weiss Ratings downgraded UnitedHealth Group from a "hold (c-)" rating to a "sell (d+)" rating in a research note on Monday, March 2nd. Mizuho decreased their target price on UnitedHealth Group from $430.00 to $350.00 and set an "outperform" rating on the stock in a research report on Thursday, February 5th. KeyCorp reiterated an "overweight" rating on shares of UnitedHealth Group in a research report on Wednesday, January 28th. Leerink Partners reduced their target price on shares of UnitedHealth Group from $410.00 to $345.00 and set an "outperform" rating on the stock in a report on Wednesday, January 28th. Finally, Wells Fargo & Company dropped their price target on UnitedHealth Group from $400.00 to $370.00 and set an "overweight" rating for the company in a research report on Friday, January 30th. One research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $372.13.

Read Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

See Also

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2026 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines